Search Medical Condition
Please enter condition
Please choose location

Seongdong-Gu, Korea, Republic of Clinical Trials

A listing of Seongdong-Gu, Korea, Republic of clinical trials actively recruiting patients volunteers.


Found (349) clinical trials

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study with an open-label extension. The study consists of 3 phases; screening phase (1 to 4 weeks), double-blind phase (24 weeks), and Open-label extension phase (24 weeks).


0.0 miles

Learn More »

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Study is to evaluate if ART-123 given to patients who have severe sepsis complicated by at least one organ dysfunction and coagulopathy can decrease mortality.


1.66 miles

Learn More »

A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)

Primary Outcome Measure: Complete histopathological regression from baseline [Time Frame: Baseline through Week 16] Secondary Outcome Measures: - Change from baseline of CIN classification [Time Frame: Baseline through Week 16] - Change from baseline of RCI [Time Frame: Baseline through Week 16 and Week 32] - Change from baseline of ...


1.99 miles

Learn More »

Zimmer MotionLoc in Distal Tibia Fractures

Primary Endpoint: - Radiographic & clinical fracture healing at 3 months post-surgery. Secondary Endpoints: - Complications - Radiologic & clinical fracture healing at 6 weeks, 3, 6, and 12 months post-surgery. - Callus size & distribution at 6 weeks, 3, 6, and 12 months post-surgery. Radiologic fracture healing is defined ...

Phase N/A

2.06 miles

Learn More »

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)

Efficacy of aflibercept for diabetic macular edema was demonstrated in the phase III, VIVID and VISTA studies. In these studies, aflibercept was injected using the fixed dosing regimen that an intravitreal injection was performed 5 times every 4 weeks and then every 8 weeks. Although the efficacy was comparable to ...


2.15 miles

Learn More »